Sa1872 IMMUNOGENICITY OF TUMOR NECROSIS FACTOR ANTAGONISTS AND THE EFFECT OF DOSE ESCALATION TO IMPROVE DRUG CONCENTRATIONS AND ELIMINATE ANTIBODIES IN A LARGE INFLAMMATORY BOWEL DISEASE POPULATION

Tumor Necrosis Factor ◽

Dose Escalation ◽

Bowel Disease ◽

Tumor Necrosis ◽

Drug Concentrations ◽

Inflammatory Bowel ◽

Faculty Opinions recommendation of Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732092122.793568144 ◽

2019 ◽

Author(s):

Ashish Patel

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Inflammatory Bowel ◽

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

JAMA ◽

10.1001/jama.2017.16071 ◽

2017 ◽

Vol 318 (17) ◽

pp. 1679 ◽

Cited By ~ 176

Author(s):

Magali Lemaitre ◽

Julien Kirchgesner ◽

Annie Rudnichi ◽

Fabrice Carrat ◽

Mahmoud Zureik ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Inflammatory Bowel ◽

Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease

10.1016/j.cgh.2012.06.032 ◽

2012 ◽

Vol 10 (10) ◽

pp. 1079-1087 ◽

Cited By ~ 142

Author(s):

Ingrid Ordás ◽

Brian G. Feagan ◽

William J. Sandborn

Keyword(s):

Tumor Necrosis Factor ◽

Therapeutic Drug Monitoring ◽

Bowel Disease ◽

Drug Monitoring ◽

Tumor Necrosis ◽

Therapeutic Drug ◽

Inflammatory Bowel ◽

Exam 1: Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease

10.1016/j.cgh.2021.11.025 ◽

2022 ◽

Vol 20 (2) ◽

pp. e337-e338

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Serious Infections ◽

Inflammatory Bowel ◽

Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease

10.1016/j.cgh.2016.06.025 ◽

2017 ◽

Vol 15 (1) ◽

pp. 25-36.e27 ◽

Cited By ~ 57

Author(s):

Laurent Peyrin-Biroulet ◽

Gert Van Assche ◽

David Gómez-Ulloa ◽

Laura García-Álvarez ◽

Núria Lara ◽

...

Keyword(s):

Systematic Review ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Extraintestinal Manifestations ◽

Inflammatory Bowel ◽

Patterns of steroid and steroid sparing regimens among older inflammatory bowel disease (IBD) patients with contraindications to tumor necrosis factor antagonists (ANTI-TNFS)

Value in Health ◽

10.1016/j.jval.2014.03.243 ◽

2014 ◽

Vol 17 (3) ◽

pp. A40

Author(s):

S.L. Johnson ◽

C. Bartels ◽

C. Thorpe ◽

M. Palta ◽

J. Weiss ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Inflammatory Bowel ◽

Necrosis Factor ◽

Steroid Sparing

Risk of serious infections with vedolizumab versus tumor necrosis factor antagonists in patients with inflammatory bowel disease

10.1016/j.cgh.2020.12.030 ◽

2020 ◽

Author(s):

Julien Kirchgesner ◽

Rishi J. Desai ◽

Laurent Beaugerie ◽

Sebastian Schneeweiss ◽

Seoyoung C. Kim

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Serious Infections ◽

Inflammatory Bowel ◽

Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis

10.1016/j.cgh.2017.02.005 ◽

2017 ◽

Vol 15 (9) ◽

pp. 1359-1372.e6 ◽

Cited By ~ 24

Author(s):

Yun Qiu ◽

Ren Mao ◽

Bai-li Chen ◽

Sheng-hong Zhang ◽

Jing Guo ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Combination Therapy ◽

Bowel Disease ◽

Tumor Necrosis ◽

Meta Analysis ◽

Inflammatory Bowel ◽

Trough Levels ◽

Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease

Journal of Clinical Gastroenterology ◽

10.1097/mcg.0000000000000758 ◽

2017 ◽

Vol 51 (5) ◽

pp. 394-401 ◽

Cited By ~ 9

Author(s):

Tushar Shukla ◽

Siddharth Singh ◽

Parul Tandon ◽

Jeffrey D. McCurdy

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Cytomegalovirus Reactivation ◽

Inflammatory Bowel ◽

Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis

10.1016/j.cgh.2017.01.035 ◽

2017 ◽

Vol 15 (7) ◽

pp. 1061-1070.e1 ◽

Cited By ~ 11

Author(s):

Laura E. Targownik ◽

Aruni Tennakoon ◽

Stella Leung ◽

Lisa M. Lix ◽

Harminder Singh ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Temporal Trends ◽

Population Based ◽

Inflammatory Bowel ◽

Initiation Of Therapy ◽